July 25, 2017 5:39 AM ET

Pharmaceuticals

Company Overview of Mega Lifesciences Public Company Limited

Company Overview

Mega Lifesciences Public Company Limited, together with its subsidiaries, develops, manufactures, markets, and sells health food supplements, prescription pharmaceutical products, over-the-counter (OTC) products, herbal products, vitamins, and fast moving consumer goods. It operates through Brands, Distribution, and Original Equipment Manufacture segments. The company provides various complementary medicines for bone and joint, children, diabetic, herbal, heart, liver and digestive, skin, slimming, and well-being care products, as well as men’s and women’s care products and sports supplements; gastrointestinal and pain care OTC medicines; and prescription medicines in the areas of iron suppl...

909, Ample Tower

9th & 10th Floor

Bangna-Trad Road

Bangna

Bangkok,  10260

Thailand

Founded in 1982

Phone:

66 2 769 4222

Fax:

66 2 769 4244

Key Executives for Mega Lifesciences Public Company Limited

Mega Lifesciences Public Company Limited does not have any Key Executives recorded.

Mega Lifesciences Public Company Limited Key Developments

Mega Lifesciences Public Company Limited Announces Consolidated Earnings Results for First Quarter Ended March 31, 2017

Mega Lifesciences Public Company Limited announced consolidated earnings results for first quarter ended March 31, 2017. For the quarter, the company reported total income of THB 2,105.3 million against THB 1,964.8 million a year ago. EBITDA was THB 283.2 million against THB 188.8 million a year ago. EBIT was THB 243.8 million against THB 151.3 million a year ago. Profit before tax was THB 236.5 million against THB 147.9 million a year ago. Profit attributable to owners of the company was THB 191.7 million or THB 0.22 basic per share against THB 114.0 million or THB 0.13 basic per share a year ago. Adjusted net profit was THB 197.5 million against THB 115.6 million a year ago. Overall operating revenue was higher by 7.1% year-on-year, mainly driven by growth in Mega We CareTM business of 14.1% year-on-year. Operating activities generated THB 202.6 million of cash compared to THB 215.5 million in a year ago. Operating cash was slightly lower due to changes in overall working capital.

Mega Lifesciences Public Company Limited Presents at Opportunity Day Quarter 1/2017, Jun-05-2017 02:00 AM

Mega Lifesciences Public Company Limited Presents at Opportunity Day Quarter 1/2017, Jun-05-2017 02:00 AM. Venue: The Stock Exchange of Thailand, Meeting Room 603, Thailand.

Mega Lifesciences Public Company Limited Announces Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2016

Mega Lifesciences Public Company Limited announced consolidated earnings results for the fourth quarter and year ended December 31, 2016. For the quarter, the company reported total income was THB 2,603.0 million against THB 2,292.7 million a year ago. EBITDA was THB 391.8 million against THB 367.6 million a year ago. Profit before tax was THB 343.8 million against THB 324.5 million a year ago. Earnings before interest & tax (EBIT) were THB 351.5 million against THB 327.8 million a year ago. Net profit was THB 295.0 million against THB 271.2 million a year ago. Earnings per share were THB 0.34 against THB 0.31 a year ago. Increase in net profits was mainly a result of growth in revenue and stable SG&A expenses. Adjusted net profit was THB 299.8 million compared to THB 271.2 million a year ago. Operating revenue was THB 2,595.5 million compared to THB 2,282 million a year ago. For the year, the company reported total income was THB 8,842.4 million against THB 7,994.8 million a year ago. EBITDA was THB 1,106.7 million against THB 985.8 million a year ago. Profit before tax was THB 932.7 million against THB 828.0 million a year ago. Earnings before interest & tax (EBIT) were THB 955.1 million against THB 840.5 million a year ago. Net profit was THB 794.9 million against THB 695.7 million a year ago. Earnings per share were THB 0.92 against THB 0.80 a year ago. Operating activities generated THB 1,260.4 million of cash in fiscal year 2016 compared to THB 609.1 million in fiscal year 2015. Increase in operating cash was mainly a result of increase in profits and improvement in overall working capital. Adjusted net profit was THB 810.3 million compared to THB 695.7 million a year ago. Operating revenue was THB 8,810.2 million compared to THB 7,944.7 million a year ago.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mega Lifesciences Public Company Limited, please visit www.megawecare.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.